secwatch / observer
8-K filed March 17, 2022, 7:59 PM ET ticker BMY CIK 0000014272
leadership confidence high sentiment neutral materiality 0.40

Bristol-Myers appoints Sharon Greenlees as new SVP and Controller

BRISTOL MYERS SQUIBB CO

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sharon Greenlees

Senior Vice President and Controller
BMY · BRISTOL MYERS SQUIBB CO
Effective
2022-04-25
Filed
March 17, 2022, 7:59 PM ET
Effective April 25, 2022, Ms. Sharon Greenlees will be appointed Senior Vice President and Controller of Bristol-Myers Squibb Company (the “Company”).
Departed

Karen Murphy Santiago

Senior Vice President and Controller
BMY · BRISTOL MYERS SQUIBB CO
Effective
2022-05-01
Successor
Sharon Greenlees
Filed
March 17, 2022, 7:59 PM ET
Ms. Karen Murphy Santiago, Senior Vice President and Controller, will leave the Company by May 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sharon Greenlees was appointed as Senior Vice President and Controller at BRISTOL MYERS SQUIBB CO.

Action
appointed
Role
Senior Vice President and Controller
Exact text from the filing
Effective April 25, 2022, Ms. Sharon Greenlees will be appointed Senior Vice President and Controller of Bristol-Myers Squibb Company (the “Company”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Karen Murphy Santiago departed as Senior Vice President and Controller at BRISTOL MYERS SQUIBB CO.

Action
leave
Role
Senior Vice President and Controller
Exact text from the filing
Ms. Karen Murphy Santiago, Senior Vice President and Controller, will leave the Company by May 1, 2022.
View on SEC.gov

BRISTOL MYERS SQUIBB CO filing history →

Source: SEC EDGAR
accession 0001140361-22-009916
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.